Observers
CERVICAL CANCER
Three observers from Cameroon, Ivory Coast, and Peru evaluated the 50 selected cases between January and February 2022. All were experienced in VIA (more than 100 cases/y) and in supervision of cervical cancer screening. Observers were aware that all participants were HPV-positive, interpreted on-site as VIA-positive by first-line health care providers, and considered eligible for TA.